I'm LongbridgeAI, I can summarize articles.Revenue: As of FY2025, the actual value is USD 145.91 M.
EPS: As of FY2025, the actual value is USD -0.2.
EBIT: As of FY2025, the actual value is USD -48.27 M.
Consolidated Financial Performance
- Net Loss: Evolv Technologies Holdings, Inc. reported a net loss of - $33.1 million for the year ended December 31, 2025, which is an improvement from a net loss of - $54.0 million for the year ended December 31, 2024.
- Accumulated Deficit: As of December 31, 2025, the company had an accumulated deficit of - $387.8 million.
- Total Revenue: Total revenue increased by 40% year-over-year, reaching $145.9 million in 2025, up from $103.9 million in 2024.
- Gross Profit: Gross profit was $75.3 million in 2025, representing a 27% increase from $59.462 million in 2024.
- Loss from Operations: The loss from operations improved by 41%, moving from - $82.307 million in 2024 to - $48.463 million in 2025.
- Adjusted EBITDA: Adjusted EBITDA significantly improved to $11.1 million in 2025, compared to - $21.0 million in 2024, marking an improvement of $32.1 million year-over-year.
Revenue by Segment (Revenue Stream)
- Product Revenue: Totaled $21.637 million in 2025, up from $6.464 million in 2024, an increase of $15.173 million (235%). The gross profit margin improved from -66% in 2024 to -12% in 2025.
- Subscription Revenue: Reached $83.839 million in 2025, up from $65.046 million in 2024, an increase of $18.793 million (29%). The gross profit margin was 56% in 2025, a slight decrease from 57% in 2024.
- Service Revenue: Amounted to $29.375 million in 2025, up from $23.467 million in 2024, an increase of $5.908 million (25%). The gross profit margin was 71% in 2025, down from 78% in 2024.
- License Fee and Other Revenue: Generated $11.054 million in 2025, up from $8.888 million in 2024, an increase of $2.166 million (24%). The gross profit margin was 89% in 2025, down from 93% in 2024.
Geographical Revenue
- United States: Contributed $140.652 million in 2025, an increase from $99.995 million in 2024.
- Foreign: Accounted for $5.253 million in 2025, up from $3.870 million in 2024.
Operating Expenses
- Research and Development: Decreased by 12% to $20.619 million in 2025 from $23.446 million in 2024.
- Sales and Marketing: Decreased by 25% to $45.626 million in 2025 from $60.637 million in 2024.
- General and Administrative: Decreased by 3% to $54.858 million in 2025 from $56.602 million in 2024.
- Restructuring Costs: Increased by 210% to $2.662 million in 2025 from $0.860 million in 2024.
Cash Flow
- Net Cash Provided by Operating Activities: The company reported $18.669 million in 2025, a significant improvement from net cash used in operating activities of - $30.853 million in 2024.
Unique Metrics
- Annual Recurring Revenue (ARR): Increased by 21% year-over-year to $120.5 million as of December 31, 2025, from $99.4 million as of December 31, 2024.
- Remaining Performance Obligation (RPO): Increased by approximately 13% to $293.6 million as of December 31, 2025, from December 31, 2024.
Outlook / Guidance
Evolv Technologies Holdings, Inc. expects increased research and development costs for 2026 due to continued investment in product innovation. Sales and marketing costs are projected to modestly increase in 2026, driven by expansion of direct and channel investments. General and administrative expenses are anticipated to decrease in 2026 as non-recurring costs from a prior investigation and restatement are not expected to continue.